<DOC>
	<DOCNO>NCT01300130</DOCNO>
	<brief_summary>The investigator examine effect different level docosahexaenoic aicd ( long chain polyunsaturated fatty acid ) intake fatty acid composition plasma erythrocyte phospholipid maturity visually evoke potential preterm infant . As secondary outcome conversion linoleic acid alpha linolenic acid correspond long chain polyunsaturated fatty acid study . Preterm infant randomize double-blind fashion one three formula contain different amount docosahexaenoic acid first two week postnatal life . A control group receive human milk . Blood sample collect study entry 14 28 day thereafter . Uniformly 13C-labeled linoleic acid alpha linolenic acid apply orally blood sample day 28 . At postconceptional age 48 week 56 week visually evoke potential record .</brief_summary>
	<brief_title>Investigations Improving Docosahexaenoic Arachidonic Acid Content Preterm Infant Formula</brief_title>
	<detailed_description />
	<criteria>preterm birth birth weight 1000 2200 g 80 % energy intake infant formula human milk enrollment apparent genetic , gastrointestinal metabolic disorder artificial ventilation oxygen supply &gt; 30 % time enrollment administration parenteral fat emulsion ( &gt; 1 g/kg/day seven day ) study entry</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>neurological development</keyword>
	<keyword>preterm infant</keyword>
	<keyword>fatty acid status</keyword>
</DOC>